Overactive Bladder Treatment Market Overview and Growth by 2028

Overactive Bladder Treatment Market Forecast to 2028 - Analysis By Pharmacotherapy (Anticholinergics, Mirabegron, Botox, Neurostimulation, and Intravesical Instillation) and Disease Type (Idiopathic Overactive Bladder and Neurogenic Bladder)

Status : Published
Report Code : TIPRE00004082

Category : Life Sciences
No. of Pages : 209

Available Report Formats :

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

Pharmacotherapy, and Disease Type

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, UAE, UK, US

Frequently Asked Questions

What are the driving factors for the global overactive bladder treatment market across the world?

The factors that are driving the growth of the overactive bladder treatment market are urinary tract infections (UTI) which lead to increased activity in the bladder wall muscles, causing symptoms like an overactive bladder. The bacteria causing UTIs reside in the lining of urothelial cells, and they attack the host body when their innate immunity is low. Individuals with recurrent UTIs are found to have voiding dysfunction and detrusor overactivity, and these functional abnormalities may further damage the integrity of the urothelial barrier. The increasing prevalence of UTIs, coupled with the association of UTIs with overactive bladder, is one of the prominent factors contributing to the overactive bladder treatment market growth.

What is the market CAGR value of the overactive bladder treatment market during the forecast period?

The CAGR value of the overactive bladder treatment market during the forecasted period of 2022-2028 is 3.1%.

What is the estimated overactive bladder treatment market size in 2021?

The overactive bladder treatment market is estimated to be valued at US$ 4,295.93 million in 2021.

What are the growth estimates for the overactive bladder treatment market till 2028?

The overactive bladder treatment market is expected to be valued at US$ 5,333.92 million in 2028.

Who are the major players in the overactive bladder treatment market across the globe?

The overactive bladder treatment market majorly consists of the players, such as Alembic Pharmaceuticals Limited, Astellas Pharma Inc; Pfizer Inc; AbbVie Inc; Teva Pharmaceutical Industries Ltd; Endo Pharmaceuticals Inc; Hisamitsu Pharmaceutical Co., Inc; Medtronic Plc; Colorado Urology Associates, PLLC; Axonics Modulation Technologies, Inc.

Which segment by pharmacotherapy led the overactive bladder treatment market?

The mirabegron segment held the largest share of the market in 2021. However, neurostimulation is expected to grow at the highest CAGR during the forecast period.

Which region is projected to be the fastest-growing region in the global overactive bladder treatment market?

The Asia Pacific is expected to be the fastest-growing region in the overactive bladder treatment market over the forecast period due to the rising geriatric population, increasing urinary incontinence cases, and a surge in product launches.

What are overactive bladder treatments?

The sudden need to urinate causes a problem with bladder dysfunction. An overactive bladder may affect how often you pee and your urgency. Causes include abdominal trauma, infection, nerve damage, medications, and certain fluids. Treatment includes changing certain behaviors, medications, and nerve stimulation. Overactive bladder is common in people aged 65 and older. Women may have OAB at a younger age, usually around 45.

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Overactive Bladder Treatment Market– By Pharmacotherapy

1.3.2 Global Overactive Bladder Treatment Market– By Disease Type

1.3.3 Global Overactive Bladder Treatment Market – By Geography

2. Global Overactive Bladder Treatment Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Overactive Bladder Treatment Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe – PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 South & Central America – PEST Analysis

4.2.5 Middle East & Africa – PEST Analysis

4.3 Expert Opinion

5. Overactive Bladder Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Urinary Incontinence

5.1.2 Growing Incidence of Urinary Tract Infections

5.2 Key Market Restraints

5.2.1 Recalls of Therapeutic Drugs

5.3 Key Market Opportunities

5.3.1 Increasing Number of Mergers and Acquisitions

5.4 Future Trends

5.4.1 Robust Pipeline of Drugs and Successive Launch of Novel Therapies

5.5 Impact analysis

6. Global Overactive Bladder Treatment Market – Global Analysis

6.1 Global Overactive Bladder Treatment Market Revenue Forecast and Analysis

6.1.1 Global Overactive Bladder Treatment Market Revenue Forecast and Analysis

6.1.2 Global Overactive Bladder Treatment Market – Market Potential Analysis, By Region

6.1.3 Company Analysis

6.2 Comparative Company Analysis

6.2.1 Growth Strategy Analysis

6.2.2 Market Positioning of Key Players in the Overactive Bladder Treatment Market

6.2.2.1 Astellas Pharma Inc.

6.2.2.2 Allergan Plc

7. Overactive Bladder Treatment Market Analysis and Forecasts To 2028 – By Pharmacotherapy

7.1 Overview

7.2 Global Overactive Bladder Treatment Market, By Pharmacotherapy 2021 & 2028 (%)

7.3 Mirabegron

7.3.1 Overview

7.3.2 Mirabegron Market Revenue and Forecast to 2028 (US$ Million)

7.4 Botox

7.4.1 Overview

7.4.2 Botox Market Revenue and Forecast to 2028 (US$ Million)

7.5 Neurostimulation

7.5.1 Overview

7.5.2 Neurostimulation Market Revenue and Forecast to 2028 (US$ Mn)

7.5.3 Transcutaneous Sacral Nerve Stimulation

7.5.3.1 Overview

7.5.3.2 Transcutaneous Sacral Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Mn)

7.5.4 Transcutaneous Tibial Nerve Stimulation

7.5.4.1 Overview

7.5.4.2 Transcutaneous Tibial Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Mn)

7.5.5 Percutaneous Posterior Tibial Nerve Stimulation

7.5.5.1 Overview

7.5.5.2 Percutaneous Posterior Tibial Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Mn)

7.5.6 Others

7.5.6.1 Overview

7.5.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

7.6 Anticholinergics

7.6.1 Overview

7.6.2 Anticholinergics Market Revenue and Forecast to 2028 (US$ Million)

7.6.3 Solifenacin

7.6.3.1 Overview

7.6.3.2 Solifenacin Market Revenue and Forecast to 2028 (US$ Million)

7.6.4 Oxybutynin

7.6.4.1 Overview

7.6.4.2 Oxybutynin Market Revenue and Forecast to 2028 (US$ Million)

7.6.5 Fesoterodine

7.6.5.1 Overview

7.6.5.2 Fesoterodine Market Revenue and Forecast to 2028 (US$ Million)

7.6.6 Darifenacin

7.6.6.1 Overview

7.6.6.2 Darifenacin Market Revenue and Forecast to 2028 (US$ Million)

7.6.7 Tolterodine

7.6.7.1 Overview

7.6.7.2 Tolterodine Market Revenue and Forecast to 2028 (US$ Million)

7.6.8 Trospium

7.6.8.1 Overview

7.6.8.2 Trospium Market Revenue and Forecast to 2028 (US$ Million)

7.6.9 Other Anticholinergics

7.6.9.1 Overview

7.6.9.2 Other Anticholinergics Market Revenue and Forecast to 2028 (US$ Million)

7.7 Intravesical Instillation

7.7.1 Overview

7.7.2 Intravesical Instillation Market Revenue and Forecast to 2028 (US$ Mn)

8. Overactive Bladder Treatment Market Analysis and Forecasts To 2028 – By Disease Type

8.1 Overview

8.2 Global Overactive Bladder Treatment Market, By Disease Type 2021 & 2028 (%)

8.3 Idiopathic Overactive Bladder

8.3.1 Overview

8.3.2 Idiopathic Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Neurogenic Overactive Bladder

8.4.1 Overview

8.4.2 Neurogenic Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

9. Overactive Bladder Treatment Market Revenue and Forecasts to 2028 – Geographical Analysis

9.1 North America: Overactive Bladder Treatment Market

9.1.1 Overview

9.1.2 North America: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)

9.1.3 North America: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.1.3.1 North America: Overactive Bladder Treatment Market, by Anticholinergics– Revenue and Forecast to 2028 (US$ Million)

9.1.3.2 North America: Overactive Bladder Treatment Market, by Neurostimulation– Revenue and Forecast to 2028 (US$ Million)

9.1.4 North America: Overactive Bladder Treatment Market, by Disease Type– Revenue and Forecast to 2028 (US$ Million)

9.1.5 North America: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)

9.1.5.1 US: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.1 US: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.2 US: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.2.1 US: Overactive Bladder Treatment Market, by Anticholinergics– Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.2.2 US: Overactive Bladder Treatment Market, by Neurostimulation– Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.3 US: Overactive Bladder Treatment Market, by Disease Type– Revenue and Forecast to 2028 (US$ Million)

9.1.5.2 Canada: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.1 Canada: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.2 Canada: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.2.1 Canada: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.2.2 Canada: Overactive Bladder Treatment Market, by Neurostimulation– Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.3 Canada: Overactive Bladder Treatment Market, by Disease Type– Revenue and Forecast to 2028 (US$ Million)

9.1.5.3 Mexico: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.1 Mexico: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.2 Mexico: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.2.1 Mexico: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.2.2 Mexico: Overactive Bladder Treatment Market, by Neurostimulation– Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.3 Mexico: Overactive Bladder Treatment Market, by Disease Type– Revenue and Forecast to 2028 (US$ Million)

9.2 Europe: Overactive Bladder Treatment Market

9.2.1 Overview

9.2.2 Europe: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2.3 Europe: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.2.3.1 Europe: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

9.2.3.2 Europe: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

9.2.4 Europe: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

9.2.5 Europe: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)

9.2.5.1 UK: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.1.1 UK: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.1.2 UK: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.2.5.1.2.1 UK: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

9.2.5.1.2.2 UK: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

9.2.5.1.3 UK: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

9.2.5.2 Germany: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.2.1 Germany: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.2.2 Germany: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.2.5.2.2.1 Germany: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

9.2.5.2.2.2 Germany: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

9.2.5.2.3 Germany: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

9.2.5.3 France: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.3.1 France: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.3.2 France: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.2.5.3.2.1 France: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

9.2.5.3.2.2 France: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

9.2.5.3.3 France: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

9.2.5.4 Italy: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.4.1 Italy: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.4.2 Italy: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.2.5.4.2.1 Italy: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

9.2.5.4.2.2 Italy: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

9.2.5.4.3 Italy: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

9.2.5.5 Spain: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.5.1 Spain: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.5.2 Spain: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.2.5.5.2.1 Spain: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

9.2.5.5.2.2 Spain: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

9.2.5.5.3 Spain: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

9.2.5.6 Rest of Europe: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.6.1 Rest of Europe: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.6.2 Rest of Europe: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.2.5.6.2.1 Rest of Europe: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

9.2.5.6.2.2 Rest of Europe: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

9.2.5.6.3 Rest of Europe: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

9.3 Asia Pacific: Overactive Bladder Treatment Market

9.3.1 Overview

9.3.2 Asia Pacific: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)

9.3.3 Asia Pacific: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.3.3.1 Asia Pacific: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.3.3.2 Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.3.4 Asia Pacific: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.3.5 Asia Pacific: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)

9.3.5.1 China: overactive bladder treatment Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.1.1 China: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.1.2 China: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.3.5.1.2.1 China: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.3.5.1.2.2 China Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.3.5.1.3 China: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.3.5.2 Japan: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.2.1 Japan: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.2.2 Japan: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.3.5.2.2.1 Japan: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.3.5.2.2.2 Japan Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.3.5.2.3 Japan: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.3.5.3 India: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.3.1 India: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.3.2 India: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.3.5.3.2.1 India: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.3.5.3.2.2 India Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.3.5.3.3 India: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.3.5.4 South Korea: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.4.1 South Korea: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.4.2 South Korea: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.3.5.4.2.1 South Korea: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.3.5.4.2.2 South Korea Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.3.5.4.3 South Korea: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.3.5.5 Australia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.5.1 Australia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.5.2 Australia: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.3.5.5.2.1 Australia: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.3.5.5.2.2 Australia Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.3.5.5.3 Australia: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.3.5.6 Rest of Asia Pacific: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.6.1 Rest of Asia Pacific: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.6.2 Rest of Asia Pacific: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.3.5.6.2.1 Rest of Asia Pacific: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.3.5.6.2.2 Rest of Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.3.5.6.3 Rest of Asia Pacific: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.4 Middle East & Africa: Overactive Bladder Treatment Market

9.4.1 Overview

9.4.2 Middle East & Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)

9.4.3 Middle East & Africa: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.4.3.1 Middle East & Africa: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.4.3.2 Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.4.4 Middle East & Africa: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.4.5 Middle East & Africa: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)

9.4.5.1 UAE: overactive bladder treatment Market – Revenue and Forecast to 2028 (USD Million)

9.4.5.1.1 UAE: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.4.5.1.2 UAE: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.4.5.1.2.1 UAE: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.4.5.1.2.2 UAE Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.4.5.1.3 UAE: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.4.5.2 Saudi Arabia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.4.5.2.1 Saudi Arabia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.4.5.2.2 Saudi Arabia: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.4.5.2.2.1 Saudi Arabia: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.4.5.2.2.2 Saudi Arabia Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.4.5.2.3 Saudi Arabia: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.4.5.3 South Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.4.5.3.1 South Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.4.5.3.2 South Africa: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.4.5.3.2.1 South Africa: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.4.5.3.2.2 South Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.4.5.3.3 South Africa: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.4.5.4 Rest of Middle East & Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.4.5.4.1 Rest of Middle East & Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.4.5.4.2 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.4.5.4.2.1 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.4.5.4.2.2 Rest of Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.4.5.4.3 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.5 South and Central America: Overactive Bladder Treatment Market

9.5.1 Overview

9.5.2 South and Central America: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)

9.5.3 South and Central America: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (USD Million)

9.5.3.1 South and Central America: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.5.3.2 South & Central America Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.5.4 South and Central America: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (USD Million)

9.5.5 South and Central America: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)

9.5.5.1 Brazil: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.5.5.2 Brazil: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.5.5.3 Brazil: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (USD Million)

9.5.5.3.1.1 Brazil: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.5.5.3.1.2 Brazil Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.5.5.4 Brazil: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (USD Million)

9.5.6 Argentina: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.5.6.1 Argentina: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.5.6.1.1 Argentina: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (USD Million)

9.5.6.1.1.1 Argentina: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.5.6.1.1.2 Argentina Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.5.6.1.2 Argentina: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (USD Million)

9.5.6.2 Rest of South and Central America: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.5.6.2.1 Rest of South and Central America: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.5.6.2.2 Rest of South and Central America: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (USD Million)

9.5.6.2.2.1 Rest of South and Central America: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.5.6.2.2.2 Rest of South & Central America Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.5.6.2.3 Rest of South and Central America: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (USD Million)

10. Impact Of COVID-19 Pandemic on Overactive Bladder Treatment Market

10.1 North America: Impact Assessment of COVID-19 Pandemic

10.2 Europe: Impact Assessment of COVID-19 Pandemic

10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic

10.4 South & Central America: Impact Assessment of COVID-19 Pandemic

10.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

11. Overactive Bladder Treatment Market– Industry Landscape

11.1 Overview

11.2 Growth Strategies Done by the Companies in the Market, (%)

11.3 Organic Developments

11.3.1 Overview

12. Company Profiles

12.1 Alembic Pharmaceuticals Limited

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Astellas Pharma Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 AbbVie Inc

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Teva Pharmaceutical Industries Ltd

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Endo Pharmaceuticals Inc.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Hisamitsu Pharmaceutical Co.,Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Medtronic Plc

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Colorado Urology Associates, PLLC

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Axonics Modulation Technologies, Inc

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. North America: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 2. North America: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 3. North America: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 4. North America: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 5. US: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 6. US: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 7. US: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 8. US: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 9. Canada: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 10. Canada: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 11. Canada: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 12. Canada: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 13. Mexico: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 14. Mexico: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 15. Mexico: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 16. Mexico: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 17. Europe: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 18. Europe: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 19. Europe: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 20. Europe: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 21. UK: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 22. UK: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 23. UK: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 24. UK: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 25. Germany: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 26. Germany: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 27. Germany: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 28. Germany: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 29. France: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 30. France: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 31. France: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 32. France: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 33. Italy: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 34. Italy: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 35. Italy: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 36. Italy: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 37. Spain: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 38. Spain: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 39. Spain: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 40. Spain: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 41. Rest of Europe: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 42. Rest of Europe: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 43. Rest of Europe: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 44. Rest of Europe: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 45. Asia Pacific Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 46. Asia Pacific Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 47. Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)

Table 48. Asia Pacific Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 49. China Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 50. China Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 51. China Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 52. China Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 53. Japan Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 54. Japan Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 55. Japan Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 56. Japan Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 57. India Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 58. India Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 59. India Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 60. India Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 61. South Korea Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 62. South Korea Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 63. South Korea Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 64. South Korea Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 65. Australia Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 66. Australia Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 67. Australia Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 68. Australia Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 69. Rest of Asia Pacific Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 70. Rest of Asia Pacific Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 71. Rest of Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 72. Rest of Asia Pacific Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 73. Middle East & Africa Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 74. Middle East & Africa Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 75. Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 76. Middle East & Africa Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 77. UAE Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 78. UAE Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 79. UAE Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 80. UAE Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 81. Saudi Arabia Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 82. Saudi Arabia Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 83. Saudi Arabia Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 84. Saudi Arabia Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 85. South Africa Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 86. South Africa Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 87. South Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 88. South Africa Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 89. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 90. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 91. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 92. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 93. South and Central America Overactive Bladder Treatment Market, by Pharmacotherapy– Revenue and Forecast to 2028 (USD Million)

Table 94. South and Central America Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 95. South and Central America Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 96. South and Central America Overactive Bladder Treatment Market, by Disease Type– Revenue and Forecast to 2028 (USD Million)

Table 97. Brazil Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (USD Million)

Table 98. Brazil Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 99. Brazil Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 100. Brazil Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 101. Argentina Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (USD Million)

Table 102. Argentina Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 103. Argentina Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 104. Argentina Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 105. Rest of South and Central America Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (USD Million)

Table 106. Rest of South and Central America Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 107. Rest of South and Central America Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 108. Rest of South and Central America Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 109. Organic Developments Done by Companies

Table 110. Glossary of Terms

LIST OF FIGURES

Figure 1. Global Overactive Bladder Treatment Market Segmentation

Figure 2. Global Overactive Bladder Treatment Market Segmentation, By Region

Figure 3. Global Overactive Bladder Treatment Market Overview

Figure 4. Mirabegron Segment Held Largest Share by Pharmacotherapy in Overactive Bladder Treatment market

Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Global Overactive Bladder Treatment Market, By Geography (US$ Million)

Figure 7. Global Overactive Bladder Treatment Market - Leading Country Markets (US$ Million)

Figure 8. Global Overactive Bladder Treatment Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. South & Central America: PEST Analysis

Figure 13. Middle East & Africa: PEST Analysis

Figure 14. Overactive Bladder Treatment Market: Impact Analysis of Driver and Restraints

Figure 15. Global Overactive Bladder Treatment Market – Revenue Forecast and Analysis – 2020- 2028

Figure 16. Global Overactive Bladder Treatment Market – Revenue Forecast and Analysis – 2021- 2028

Figure 17. Global Overactive Bladder Treatment Market – Market Potential Analysis, By Region

Figure 18. Analysis of Key Players in Overactive Bladder Treatment Market

Figure 19. Global Overactive Bladder Treatment Market – Comparative Company Analysis

Figure 20. Global Overactive Bladder Treatment Market – Growth Strategy Analysis

Figure 21. Global Overactive Bladder Treatment Market, by Pharmacotherapy 2021 & 2028 (%)

Figure 22. Mirabegron Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Botox Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Neurostimulation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. Transcutaneous Sacral Nerve Stimulation Market Revenue and Forecasts To 2028 (US$ MN)

Figure 26. Transcutaneous Tibial Nerve Stimulation Market Revenue and Forecasts To 2028 (US$ MN)

Figure 27. Percutaneous Posterior Tibial Nerve Stimulation Market Revenue and Forecasts To 2028 (US$ MN)

Figure 28. Others Market Revenue and Forecasts To 2028 (US$ MN)

Figure 29. Anticholinergics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 30. Solifenacin Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31. Oxybutynin Market Revenue and Forecasts To 2028 (US$ Million)

Figure 32. Fesoterodine Market Revenue and Forecasts To 2028 (US$ Million)

Figure 33. Darifenacin Market Revenue and Forecasts To 2028 (US$ Million)

Figure 34. Tolterodine Market Revenue and Forecasts To 2028 (US$ Million)

Figure 35. Trospium Market Revenue and Forecasts To 2028 (US$ Million)

Figure 36. Other Anticholinergics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 37. Intravesical Instillation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 38. Global Overactive Bladder Treatment Market, by Disease Type 2021 & 2028 (%)

Figure 39. Idiopathic Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40. Neurogenic Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41. North America: Overactive Bladder Treatment Market Revenue Overview, By Key Country – Revenue (2021) (US$ Million)

Figure 42. North America: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)

Figure 43. North America: Overactive Bladder Treatment Market, By Country, 2021 & 2028 (%)

Figure 44. US: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)

Figure 45. Canada: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)

Figure 46. Mexico: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)

Figure 47. Europe: Overactive Bladder Treatment Market, by Key Country – Revenue (2021) (US$ Million)

Figure 48. Europe: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 49. Europe: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)

Figure 50. UK: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 51. Germany: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 52. France: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 53. Italy: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 54. Spain: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 55. Rest of Europe: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 56. Asia Pacific: Overactive Bladder Treatment Market, by Key Country – Revenue (2021) (US$ Million)

Figure 57. Asia Pacific Overactive Bladder Treatment Market Revenue and Forecast to 2028 (USD Million)

Figure 58. China: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 59. Japan: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 60. India: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 61. South Korea: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 62. Australia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 63. Rest of Asia Pacific: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 64. Middle East & Africa: Overactive Bladder Treatment Market, by Key Country – Revenue (2021) (US$ Million)

Figure 65. Middle East & Africa Overactive Bladder Treatment Market Revenue and Forecast to 2028 (USD Million)

Figure 66. UAE: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 67. Saudi Arabia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 68. South Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 69. Rest of Middle East & Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 70. South and Central America: Overactive Bladder Treatment Market, by Key Country – Revenue (2021) (USD Million)

Figure 71. South and Central America Overactive Bladder Treatment Market Revenue and Forecast to 2028 (USD Million)

Figure 72. Brazil: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 73. Argentina: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 74. Rest of South and Central America: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 75. Impact of COVID-19 Pandemic on North American Country Markets

Figure 76. Impact of COVID-19 Pandemic in European Countries Markets

Figure 77. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets

Figure 78. Impact of COVID-19 Pandemic on South and Central America Country Markets

Figure 79. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets

Figure 80. Growth Strategies Done by the Companies in the Market, (%)

Your Key Concerns Addressed - Question & Answer

Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.

Is there support available if I can't access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
Validates and strengthens in-house secondary research findings
Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

Industry participants: VPs, business development managers, market intelligence managers and national sales managers
Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Please use your business email for quicker response

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.